Facts & Figures
Global headquarters | Aubagne, France |
Legal structure | Sartorius Stedim Biotech S.A. is listed on the stock exchange in Paris, France. Sartorius AG holds approximately 74% of the share capital and around 85% of the voting rights of Sartorius Stedim Biotech S.A. |
Annual sales Revenue 2018 | 1,212.2 million euros |
- of which EMEA | 42% |
- of which Americas | 35% |
- of which Asia | Pacific | 23% |
Underlying EBITDA Underlying EBITDA margin | 342.4 million euros 28.2% |
Capex ratio | 14.6% |
Number of employees (as Dec 31, 2018) | 5,600 |